801 related articles for article (PubMed ID: 11823786)
21. Subunit-specific roles of glycine-binding domains in activation of NR1/NR3 N-methyl-D-aspartate receptors.
Awobuluyi M; Yang J; Ye Y; Chatterton JE; Godzik A; Lipton SA; Zhang D
Mol Pharmacol; 2007 Jan; 71(1):112-22. PubMed ID: 17047094
[TBL] [Abstract][Full Text] [Related]
22. Endoplasmic reticulum-associated degradation of the NR1 but not the NR2 subunits of the N-methyl-D-aspartate receptor induced by inhibition of the N-glycosylation in cortical neurons.
Gascón S; García-Gallo M; Renart J; Díaz-Guerra M
J Neurosci Res; 2007 Jun; 85(8):1713-23. PubMed ID: 17455306
[TBL] [Abstract][Full Text] [Related]
23. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
24. The contribution of the NMDA receptor glycine site to rhythm generation during fictive swimming in Xenopus laevis tadpoles.
Issberner JP; Sillar KT
Eur J Neurosci; 2007 Nov; 26(9):2556-64. PubMed ID: 17970719
[TBL] [Abstract][Full Text] [Related]
25. Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits.
Chandra T; Maier W; König HG; Hirzel K; Kögel D; Schüler T; Chandra A; Demirhan I; Laube B
Neuroscience; 2005; 134(1):145-53. PubMed ID: 15964699
[TBL] [Abstract][Full Text] [Related]
26. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology.
Monaghan DT; Larsen H
J Pharmacol Exp Ther; 1997 Feb; 280(2):614-20. PubMed ID: 9023271
[TBL] [Abstract][Full Text] [Related]
27. Residues at the tip of the pore loop of NR3B-containing NMDA receptors determine Ca2+ permeability and Mg2+ block.
Cavara NA; Orth A; Hicking G; Seebohm G; Hollmann M
BMC Neurosci; 2010 Oct; 11():133. PubMed ID: 20958962
[TBL] [Abstract][Full Text] [Related]
28. Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
Hess SD; Daggett LP; Crona J; Deal C; Lu CC; Urrutia A; Chavez-Noriega L; Ellis SB; Johnson EC; Veliçelebi G
J Pharmacol Exp Ther; 1996 Aug; 278(2):808-16. PubMed ID: 8768735
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract][Full Text] [Related]
30. Expression and characterization of a glycine-binding fragment of the N-methyl-D-aspartate receptor subunit NR1.
Miyazaki J; Nakanishi S; Jingami H
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):687-92. PubMed ID: 10359652
[TBL] [Abstract][Full Text] [Related]
31. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
[TBL] [Abstract][Full Text] [Related]
32. Modulation of NMDA receptor properties and synaptic transmission by the NR3A subunit in mouse hippocampal and cerebrocortical neurons.
Tong G; Takahashi H; Tu S; Shin Y; Talantova M; Zago W; Xia P; Nie Z; Goetz T; Zhang D; Lipton SA; Nakanishi N
J Neurophysiol; 2008 Jan; 99(1):122-32. PubMed ID: 18003876
[TBL] [Abstract][Full Text] [Related]
33. Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes.
Chen PE; Geballe MT; Katz E; Erreger K; Livesey MR; O'Toole KK; Le P; Lee CJ; Snyder JP; Traynelis SF; Wyllie DJ
J Physiol; 2008 Jan; 586(1):227-45. PubMed ID: 17962328
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase C modulates NMDA receptor trafficking and gating.
Lan JY; Skeberdis VA; Jover T; Grooms SY; Lin Y; Araneda RC; Zheng X; Bennett MV; Zukin RS
Nat Neurosci; 2001 Apr; 4(4):382-90. PubMed ID: 11276228
[TBL] [Abstract][Full Text] [Related]
35. Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor.
Masuko T; Nagaoka H; Miyake M; Metori K; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
Neurochem Int; 2007 Jan; 50(2):443-9. PubMed ID: 17113196
[TBL] [Abstract][Full Text] [Related]
36. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
[TBL] [Abstract][Full Text] [Related]
37. Single channel analysis of a novel NMDA channel from Xenopus oocytes expressing recombinant NR1a, NR2A and NR2D subunits.
Cheffings CM; Colquhoun D
J Physiol; 2000 Aug; 526 Pt 3():481-91. PubMed ID: 10922001
[TBL] [Abstract][Full Text] [Related]
38. A developmental influence of the N-methyl-D-aspartate receptor NR3A subunit on prepulse inhibition of startle.
Brody SA; Nakanishi N; Tu S; Lipton SA; Geyer MA
Biol Psychiatry; 2005 May; 57(10):1147-52. PubMed ID: 15866554
[TBL] [Abstract][Full Text] [Related]
39. The NR3B subunit does not alter the anesthetic sensitivities of recombinant N-methyl-D-aspartate receptors.
Yamakura T; Askalany AR; Petrenko AB; Kohno T; Baba H; Sakimura K
Anesth Analg; 2005 Jun; 100(6):1687-1692. PubMed ID: 15920196
[TBL] [Abstract][Full Text] [Related]
40. Analysis of NR3A receptor subunits in human native NMDA receptors.
Nilsson A; Eriksson M; Muly EC; Akesson E; Samuelsson EB; Bogdanovic N; Benedikz E; Sundström E
Brain Res; 2007 Dec; 1186():102-12. PubMed ID: 17997397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
